University of Wisconsin–Madison

Daniel E. Abbott, MD, FACS

Associate Professor

  • Surgical Director, UW Health Liver and Pancreas Center
  • Division of Surgical Oncology
(608) 262-2025

600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792


  • MD, University of Washington School of Medicine, Seattle, Washington, 2003
  • General Surgery Residency, Northwestern University/Feinberg School of Medicine, Chicago, Illinois, 2010
  • Research Fellowship, Children's Memorial Research Center/Northwestern University, Division of Cancer Biology and Epigenomics, Chicago, Illinois, 2008
  • Surgical Oncology Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2012

Clinical Specialties

Dr. Abbott is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. Trained specifically in cancer surgery at The University of Texas MD Anderson Cancer Center, his clinical focus is on gastrointestinal malignancies, as well as melanoma and sarcoma. He performs both traditional and laparoscopic resections for cancers of the liver, pancreas, and stomach. As Director of Cytoreductive and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgery, he is particularly interested in patients with peritoneal spread of appendiceal, colorectal and ovarian cancers. Dr. Abbott is active in a number of national organizations, including the Society of Surgical Oncology, the American Hepatopancreaticobiliary Association, the Association for Academic Surgery, and the Society of University Surgeons.

Research Interests

Dr. Abbott, a health services researcher, focuses on cost-effectiveness, systems efficiency, and socioeconomic disparity in cancer care. He is particularly interested in identifying opportunities to maintain or enhance cancer care using technology in a patient-centered manner and thereby helping patients access expert cancer care in more personalized settings.

Recent Publications

    • Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.
    • Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola-Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM
    • Surgery 2018 Oct 27;
    • [PubMed ID: 30377003]
    • Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium.
    • Kerlakian S, Dhar VK, Abbott DE, Kooby DA, Merchant NB, Kim HJ, Martin RC, Scoggins CR, Bentrem DJ, Weber SM, Maithel SK, Ahmad SA, Patel SH
    • HPB (Oxford) 2018 Oct 23;
    • [PubMed ID: 30361110]
    • Cohort Study of Overutilization of Preventive Screening for Patients With Pancreatic Cancer.
    • Fisher AV, Abbott DE, Fernandes-Taylor S, Havlena JA, Wang X, Shan Y, Lawson EH, Winslow ER, Weber SM, Schumacher JR
    • Pancreas 2018 Oct; 47(9): e65-e67
    • [PubMed ID: 30199493]
    • Role of associating liver partition and portal vein ligation in staged hepatectomy (ALPPS)-strategy for colorectal liver metastases.
    • Abbasi A, Rahnemai-Azar AA, Merath K, Weber SM, Abbott DE, Dillhoff M, Cloyd J, Pawlik TM
    • Transl Gastroenterol Hepatol 2018; 3: 66
    • [PubMed ID: 30363643]
    • Adaptation and Implementation of a Transitional Care Protocol for Patients Undergoing Complex Abdominal Surgery.
    • Fisher AV, Campbell-Flohr SA, Sell L, Osterhaus E, Acher AW, Leahy-Gross K, Brenny-Fitzpatrick M, Kind AJH, Carayon P, Abbott DE, Winslow ER, Greenberg CC, Fernandes-Taylor S, Weber SM
    • Jt Comm J Qual Patient Saf 2018 Dec; 44(12): 741-750
    • [PubMed ID: 30097384]

All Publications on PubMed